ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Cumulex NV

Cumulex NV (CLEX)

1.30
0.36
(38.30%)
Closed April 28 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.30
Bid
0.62
Ask
1.30
Volume
200
1.30 Day's Range 1.30
0.54 52 Week Range 1.35
Market Cap
Previous Close
0.94
Open
1.30
Last Trade
1
@
1.3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
41
Shares Outstanding
1,835,000
Dividend Yield
-
PE Ratio
-33.59
Earnings Per Share (EPS)
-0.04
Revenue
-
Net Profit
-71k

About Cumulex NV

Sector
Beet Sugar
Industry
Beet Sugar
Website
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
-
Cumulex NV is listed in the Beet Sugar sector of the Euronext with ticker CLEX. The last closing price for Cumulex NV was 0.94 â‚¬. Over the last year, Cumulex NV shares have traded in a share price range of 0.54 â‚¬ to 1.35 â‚¬.

Cumulex NV currently has 1,835,000 shares outstanding. The market capitalization of Cumulex NV is 1.72 â‚¬ million. Cumulex NV has a price to earnings ratio (PE ratio) of -33.59.

CLEX Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3638.29787234040.941.30.9400DE
40.5983.09859154930.711.30.71100.75458599DE
12-0.02-1.515151515151.321.320.585410.64061002DE
260.1816.07142857141.121.350.54460.7961093DE
520.1513.04347826091.151.350.54250.84319279DE
156-1-43.47826086962.32.960.54291.42801302DE
260-0.4298-24.84680309861.72984.860.54612.23747161DE

CLEX - Frequently Asked Questions (FAQ)

What is the current Cumulex NV share price?
The current share price of Cumulex NV is 1.30 â‚¬
How many Cumulex NV shares are in issue?
Cumulex NV has 1,835,000 shares in issue
What is the market cap of Cumulex NV?
The market capitalisation of Cumulex NV is EUR 1.72M
What is the 1 year trading range for Cumulex NV share price?
Cumulex NV has traded in the range of 0.54 â‚¬ to 1.35 â‚¬ during the past year
What is the PE ratio of Cumulex NV?
The price to earnings ratio of Cumulex NV is -33.59
What is the reporting currency for Cumulex NV?
Cumulex NV reports financial results in EUR
What is the latest annual profit for Cumulex NV?
The latest annual profit of Cumulex NV is EUR -71k
What is the registered address of Cumulex NV?
The registered address for Cumulex NV is BORDER STREET 7, DIEGEM, BRUSSELS, BRUSSELS-CAPITAL REGION, 1831
What is the Cumulex NV website address?
The website address for Cumulex NV is www.cumulex.be
Which industry sector does Cumulex NV operate in?
Cumulex NV operates in the BEET SUGAR sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PHXMPHAXIAM Therapeutics SA
0.468 â‚¬
(208.91%)
512.65k
DMSBSDiagnostic Medical Systems
0.009 â‚¬
(157.14%)
5.55k
ALSENSensorion
0.4065 â‚¬
(94.31%)
4.53M
MLCOTCoretech 5
0.0295 â‚¬
(47.50%)
21.4k
CLEXCumulex NV
1.30 â‚¬
(38.30%)
200
ALALOAcheterLouerFR
0.0003 â‚¬
(-25.00%)
49.2M
MLGEQGentlemen S Equity SA
0.015 â‚¬
(-18.92%)
400
FPGUnion Tech Info
0.10 â‚¬
(-15.97%)
5.58k
ALVERVergnet
0.0006 â‚¬
(-14.29%)
337.31M
ALNMRNamR SA
0.243 â‚¬
(-13.83%)
10k
ALVERVergnet
0.0006 â‚¬
(-14.29%)
337.31M
ALEUPEuroplasma
0.0148 â‚¬
(-12.94%)
263.34M
BCPBanco Comercial Portugues SA
0.5616 â‚¬
(-1.20%)
74.89M
ALALOAcheterLouerFR
0.0003 â‚¬
(-25.00%)
49.2M
ALHPIHopium SA
0.0009 â‚¬
(0.00%)
43.95M

Discussion

View Full Feed
imafan imafan 2 minutes ago
Eeyore has spoken! AKA professed lying short. Real News: HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING!!!
HHSE
StockItOut StockItOut 2 minutes ago
Another SmartyPants/Quester lie, or you have a filing to support your assertion?
XERI
fuagf fuagf 3 minutes ago
LOL Figured that comment would grab you. 🙃 Qualification to mine would be, of course, unless they had firm numbers wrapped up with more security than Fort Knox. While fully appreciating the gravity you see in the situation, and though I've read little lately, still am guessing it's better t
glenn1919 glenn1919 3 minutes ago
CTMX..............................................a/h
CTMX
dia76ca dia76ca 3 minutes ago
"Blarcamesine and Anavex 3-71 are changing the paradigm for the treatment of neurodegenerative and neurodevelopmental diseases."
Nice summary georgejjl !
Paradigm shifts are very exciting but some folks see them before others!
The rest of this year will be pivotal.
2026 s
AVXL
Lykiri Lykiri 3 minutes ago
Actually, there’s a bit of confusion here. Under the old regulation, both positive and negative recommendations were referred to the CHM for review. However, the new regulation (effective after 3 April 2025) stipulates that only applications with serious concerns are now referred to the CHM. Therefo
NWBO
I-Glow I-Glow 4 minutes ago
And the Hindenburg report.- https://hindenburgresearch.com/mullen/.

Plus, TenKay was all over the preferred shares and the financials.

IG
MULN
boi568 boi568 4 minutes ago
Even if an ADL "odds ratio" claim could normally be considered disqualifying in lieu of a comparison of the means, it just seems to me irrelevant to the EMA here, since ADL itself is a not ready for prime time EMA endpoint in an early AD trial.
AVXL
dennisdave dennisdave 4 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting Ok interesting
NWBO
hedge_fun hedge_fun 5 minutes ago
That’s what I said, you’re smarter than……

the markets.

In your opinion of course!
TSLA
WarMachine WarMachine 5 minutes ago
I couldn't imagine making such a fool of myself every day on a public forum.
You don't need to imagine it. LOL
they are beyond clueless about what's really happening here
Explain, IN DETAIL, with PROOF to validate your claims, EXACTLY what is going on here. Or is it YOU who is
MONI
Uncle Monkey Uncle Monkey 6 minutes ago
wow! huge MAGA action today. FSR

hahaha
CBRF
Natural Trader Natural Trader 6 minutes ago
it does with high PT
exwannabe exwannabe 7 minutes ago
Impossible, they have to by law. They cant simply stop discussion because NWBO "might" get refusal.
I do not claim to know how the MHRA-NICE communications work.

But I do think I understand the NICE process well enough. They are at hold waiting for the evidence submission. Ever
NWBO
Truenorth2016 Truenorth2016 7 minutes ago
Any Dip Before News IMO is a Golden Opportunity Set-up!!!
CAVR
skitahoe skitahoe 8 minutes ago
There have been many bashers here saying that NICE wouldn't even speak to the company, and it would be next year or later before they would be able to treat patients with payment from the UK healthcare system. It seems like they're very wrong and the system may be ready for patients very shortly af
NWBO
dennisdave dennisdave 8 minutes ago
so it's your belief Linda dares not to disclose negative material news Ofcourse she will but I think they will probably do that when there is no more escape route IF there is bad news to report. The 10K left them no option had they prior to that received bad news so I am pretty sure they didn't rece
NWBO
manibiotech manibiotech 8 minutes ago
I agree with your points . However there were medicines last year which got approved by MHRA but NICE decided not to get them covered by NHS same day or so. Those companies would have been in discussions with NICE before MHRA approval . So not really sure it is absolutely comforting . Looks like the
NWBO
fwb fwb 8 minutes ago
You have issues,
find a woman
Let her HELP YOU get RIGHT... if you know what I mean
PLTR
I-Glow I-Glow 9 minutes ago
I believe there is a caveat to that provision as the company also has to be Deficienct in another listing requirement.

TK, can explain it much better as well as others.

IG
MULN
ddls ddls 9 minutes ago
4/28/25, Buy: 525,000, Neutral: 4,076,000, Sell: 11,275,500

One last day buy ask slap trade to make this junk look good.
BIEL
archilles archilles 9 minutes ago
Isn’t there a newly graduated law student recently passed the bar exam lawyer who will take on this case for experience for small pro bono fees. This should be a relatively easy to identify the bad guys and the victims. What we have here are the victim shareholders, who got ripped off, versus the
ENZC